Capriona SAS

Capriona SAS is a declared insider of Neolife, with filings sourced from AMF. Over a trading history stretching from 25 July 2023 to 22 June 2026, the count stands at 20 filings.

No open-market sale appears; the market trades are 20 purchases worth €281k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 15 purchases and no sales.

Half of the purchases are above €12k and half below. Relative to company size, the median is 0.17% of market cap (15 purchases with a known value). On 4 out of 20 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 20 purchases show a median change of -9.8%, with the price up in 45% of them. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 23 June 2026: an open-market purchase of €9,990, in Neolife. Filings reach the AMF feed a median of 4 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.